pentobarbital will reduce the extent or effect of etravirine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.

pentobarbital will reduce the extent or result of estrogens esterified by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

pentobarbital will decrease the extent or influence of alfuzosin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Not known.

Training caution whenever a barbiturate is administered into a nursing woman; little quantities of barbiturates are excreted within the milk

pentobarbital will lessen the extent or outcome of fosphenytoin by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Watch.

Remark: Barbiturates may possibly boost adverse effects, which includes respiratory despair, produced by harmful doses of TCAs. With therapeutic doses of TCAs, barbiturates boost metabolism and reduce blood concentrations of TCAs.

fentanyl transdermal and pentobarbital equally maximize sedation. Stay away from or Use Alternate Drug. Limit use to patients for whom alternate treatment choices are insufficient

Reserve concomitant prescribing of these drugs in people for whom other cure selections are insufficient. Restrict dosages and durations for the least demanded. Keep track of closely for indications of respiratory despair and sedation.

pentobarbital will lessen the extent or impact of efavirenz by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Unidentified.

This drug may perhaps interfere with the absorption of orally administered griseofulvin, reducing its blood concentrations; effects of blood degree buy pentobarbital sodium salt reduction not known; preferable to stop concomitant administration of these drugs

pentobarbital will lower the level or effect of duvelisib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Coadministration with a solid CYP3A inducer decreases duvelisib space beneath the curve (AUC), which may reduce duvelisib efficacy.

pentobarbital will lessen the extent or result of ambrisentan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Mysterious.

With therapeutic doses of TCAs, barbiturates maximize metabolism and decrease blood concentrations of TCAs.

pentobarbital will lessen the extent or impact of sulfamethoxazole by impacting hepatic enzyme CYP2C9/10 metabolism. Minimal/Importance Unknown.